Issues & Trends

FNC Executives Make a Series of Treasury Stock Purchases… "Emphasizing Commitment to Responsible Management"

President Han Seung-hoon Buys 29,687 Shares of Common Stock on the Open Market Key Executives Purchase a Total of 50,565 Shares of Company Stock

KIM HYUNSIK
2026-07-30 18:19:06
[Edaily Reporter KIM HYUNSIK ] FNC ENTERTAINMENT Co., Ltd. (173940) announced that “President Han Seung-hoon, a related party of the largest shareholder, purchased 29,687 shares of the company’s common stock on the open market.”
(Photo = FNC)
Previously, on the 20th, FNC announced that “CEO Kim Yu-sik had purchased 20,878 shares of the company’s common stock on the open market.” Following CEO Kim’s purchase, President Han’s acquisition brings the total number of shares purchased by key executives this month to 50,565. Regarding this, FNC stated, “This once again underscores our commitment to enhancing corporate value and responsible management.”
CEO Kim stated on the same day, “Despite the trend of improving performance, we believe the stock price is currently excessively undervalued due to supply-and-demand issues,” adding, “We expect the stock price to show a gradual upward trend once operating revenue expands and supply-and-demand issues improve.”
FNC ENTERTAINMENT Co., Ltd. is a comprehensive entertainment company encompassing music, artist management, and drama production. Its roster of artists includes FT Island, CNBLUE, N.Flying, SF9, P1Harmony, &One, AMP, Flare U, Jung Hae-in, and Rowoon.

Economy

Corporation

IT·Science

Economy

"Cutting Wages If We Run a Deficit?" SK Hanik Union 'Fumes'

Management and labor at SK hynix are struggling to bridge their differences in this year’s wage and collective bargaining negotiations over the method of paying performance bonuses and the restructuri…
2026-07-31 12:01:46

IT·Science

Onconic Therapeutics Inc. “Zacubo” Receives Recommendation for Marketing Approval in India

#Onconic Therapeutics Inc. is accelerating its expansion into India. Onconic Therapeutics Inc.’s new drug for gastroesophageal reflux disease (GERD), Jacubo, has received a recommendation for marketin…
2026-07-31 14:41:02